Carboplatin, Docetaxel, Pertuzumab, and Trastuzumab
About
Membership operator: AND
Therapies: 4
Therapies
Carboplatin (tx:ncit:C1282)
Docetaxel (tx:ncit:C1526)
Pertuzumab (tx:ncit:C38692)
Trastuzumab (tx:ncit:C1647)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (4) | HER2-positive | Invasive Breast Carcinoma | Carboplatin, Docetaxel, Pertuzumab, Trastuzumab |